Tony Cardenas actually said...

"Biosimilars hold the potential to help cut down these costs with marketed biosimilars being priced an average of 40 percent less than the biologic."

"HHS is better qualified with expertise to deal with children, especially when they are separated from their family."

"I think it is important and I thank you, Mr. Chairman, for us taking on this responsibility because when we don't do our job as a legislature then we leave the appointed officials to do the job."

"has HHS already instituted policies, protocols, and procedures to limit harm to children and their families during these separations?"